Somatostatin-based radiotherapy with [(90)Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study

BACKGROUND: We describe the long-term outcome after clinical introduction and dose escalation of somatostatin receptor targeted therapy with [(90)Y-DOTA]-TOC in patients with metastasized neuroendocrine tumors. METHODS: In a clinical phase I dose escalation study we treated patients with increasing...

Descripción completa

Detalles Bibliográficos
Autores principales: Marincek, Nicolas, Jörg, Ann-Catherine, Brunner, Philippe, Schindler, Christian, Koller, Michael T, Rochlitz, Christoph, Müller-Brand, Jan, Maecke, Helmut R, Briel, Matthias, Walter, Martin A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561188/
https://www.ncbi.nlm.nih.gov/pubmed/23320604
http://dx.doi.org/10.1186/1479-5876-11-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561188/
https://www.ncbi.nlm.nih.gov/pubmed/23320604
http://dx.doi.org/10.1186/1479-5876-11-17

Ejemplares similares